ANAVEX LIFE SCIENCES CORP. Operating Leases, Rent Expense
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Operating Leases, Rent Expense of $30.07 thousand for the 3-month period ending 2022-12-31, per its 10-Q filed 2023-02-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2023-02-07
- ANAVEX LIFE SCIENCES CORP. operating leases, rent expense for the quarter ending 2022-12-31 was $30.07K, a 520.64% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. operating leases, rent expense for the quarter ending 2022-03-31 was $16.49K, a 44.86% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. operating leases, rent expense for the quarter ending 2021-12-31 was $4.84K, a 92.92% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. operating leases, rent expense for the quarter ending 2021-09-30 was $13.50K, a 78.89% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. operating leases, rent expense for fiscal 2022 was $72.86K, a 44.29% decline from fiscal 2021.
- ANAVEX LIFE SCIENCES CORP. operating leases, rent expense for fiscal 2021 was $130.78K, a 43.97% decline from fiscal 2020.
- ANAVEX LIFE SCIENCES CORP. operating leases, rent expense for fiscal 2020 was $233.42K, a 22.59% increase from fiscal 2019.
- ANAVEX LIFE SCIENCES CORP. operating leases, rent expense for fiscal 2019 was $190.42K.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 3 month as first filed | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 6 month as first filed | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 89 month | Operating Leases, Rent Expense 92 month | Operating Leases, Rent Expense 95 month | Operating Leases, Rent Expense 98 month | Operating Leases, Rent Expense 101 month | Operating Leases, Rent Expense 104 month | Operating Leases, Rent Expense 107 month | Operating Leases, Rent Expense 110 month | Operating Leases, Rent Expense 113 month | Operating Leases, Rent Expense 116 month | Operating Leases, Rent Expense 119 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-31 | $30.07K 10-Q · filed 2023-02-07 | ||||||||||||||||
| 2022-09-30 | $72.86K 10-K · filed 2022-11-28 | ||||||||||||||||
| 2022-03-31 | $16.49K 10-Q · filed 2022-05-10 | $21.33K 10-Q · filed 2022-05-10 | $34.83K derived: sum of 3 quarters · filed 2023-02-07 | $53.83K derived: sum of 4 quarters · filed 2023-02-07 | |||||||||||||
| 2021-12-31 | $4.84K 10-Q · filed 2023-02-07 | $18.34K derived: sum of 2 quarters · filed 2023-02-07 | $37.34K derived: sum of 3 quarters · filed 2023-02-07 | $67.24K derived: sum of 4 quarters · filed 2023-02-07 | |||||||||||||
| 2021-09-30 | $13.50K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | $32.49K derived: sum of 2 quarters · filed 2022-11-28 | $62.40K derived: sum of 3 quarters · filed 2022-11-28 | $130.78K 10-K · filed 2022-11-28 | |||||||||||||
| 2021-06-30 | $18.99K 10-Q · filed 2021-08-12 | $48.90K derived: sum of 2 quarters · filed 2022-05-10 | $117.28K 10-Q · filed 2021-08-12 | $181.24K derived: sum of 4 quarters · filed 2022-11-28 | |||||||||||||
| 2021-03-31 | $29.90K 10-Q · filed 2022-05-10 | $98.29K 10-Q · filed 2022-05-10 | $60.86K 10-Q · filed 2021-05-13 | $162.24K derived: sum of 3 quarters · filed 2022-11-28 | $220.80K derived: sum of 4 quarters · filed 2022-11-28 | ||||||||||||
| 2020-12-31 | $68.39K 10-Q · filed 2022-02-09 | $132.34K derived: sum of 2 quarters · filed 2022-11-28 | $190.90K derived: sum of 3 quarters · filed 2022-11-28 | $289.19K derived: sum of 4 quarters · filed 2022-11-28 | |||||||||||||
| 2020-09-30 | $63.95K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | $122.51K derived: sum of 2 quarters · filed 2022-11-28 | $220.80K derived: sum of 3 quarters · filed 2022-11-28 | $233.42K 10-K · filed 2022-11-28 | |||||||||||||
| 2020-06-30 | $58.55K 10-Q · filed 2021-08-12 | $156.84K derived: sum of 2 quarters · filed 2021-08-12 | $169.47K 10-Q · filed 2021-08-12 | $269.51K derived: sum of 4 quarters · filed 2021-08-12 | |||||||||||||
| 2020-03-31 | $98.29K 10-Q · filed 2021-05-13 | $60.86K 10-Q · filed 2020-05-07 | $110.92K 10-Q · filed 2021-05-13 | $210.95K derived: sum of 3 quarters · filed 2021-05-13 | $260.50K derived: sum of 4 quarters · filed 2021-05-13 | ||||||||||||
| 2019-12-31 | $50.05K 10-Q · filed 2021-02-16 | $112.66K derived: sum of 2 quarters · filed 2021-02-16 | $162.21K derived: sum of 3 quarters · filed 2021-02-16 | $202.72K derived: sum of 4 quarters · filed 2021-02-16 | |||||||||||||
| 2019-09-30 | $62.61K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-28 | $112.16K derived: sum of 2 quarters · filed 2020-12-28 | $152.66K derived: sum of 3 quarters · filed 2020-12-28 | $190.42K 10-K · filed 2020-12-28 | |||||||||||||
| 2019-06-30 | $49.55K 10-Q · filed 2020-08-06 | $90.05K derived: sum of 2 quarters · filed 2020-08-06 | $127.81K 10-Q · filed 2020-08-06 | ||||||||||||||
| 2019-03-31 | $40.51K 10-Q · filed 2020-05-07 | $78.26K 10-Q · filed 2020-05-07 | |||||||||||||||
| 2018-12-31 | $37.75K 10-Q · filed 2020-02-06 | ||||||||||||||||
| 2013-12-31 | $12.00K 10-Q · filed 2014-02-14 | $24.00K derived: sum of 2 quarters · filed 2014-02-14 | $24.00K derived: sum of 3 quarters · filed 2014-02-14 | $24.00K derived: sum of 4 quarters · filed 2014-02-14 | $248.67K 10-Q · filed 2014-02-14 | ||||||||||||
| 2013-09-30 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30 | $12.00K derived: sum of 2 quarters · filed 2013-12-30 | $12.00K derived: sum of 3 quarters · filed 2013-12-30 | $12.00K 10-K · filed 2013-12-30 | $236.67K 10-K · filed 2013-12-30 | ||||||||||||
| 2013-06-30 | $0.00 10-Q · filed 2013-08-14 | $0.00 derived: sum of 2 quarters · filed 2013-08-14 | $0.00 10-Q · filed 2013-08-14 | $0.00 derived: sum of 4 quarters · filed 2014-02-14 | $224.67K 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-17 | $0.00 10-Q · filed 2013-05-17 | $0.00 derived: sum of 3 quarters · filed 2014-02-14 | $0.00 derived: sum of 4 quarters · filed 2014-02-14 | $224.67K 10-Q · filed 2013-05-17 | ||||||||||||
| 2012-12-31 | $0.00 10-Q · filed 2014-02-14 | $0.00 derived: sum of 2 quarters · filed 2014-02-14 | $0.00 derived: sum of 3 quarters · filed 2014-02-14 | $0.00 derived: sum of 4 quarters · filed 2014-02-14 | $224.67K 10-Q · filed 2013-02-14 | ||||||||||||
| 2012-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30 | $0.00 derived: sum of 2 quarters · filed 2013-12-30 | $0.00 derived: sum of 3 quarters · filed 2013-12-30 | $0.00 10-K · filed 2013-12-30 | $224.67K 10-K · filed 2012-12-31 | ||||||||||||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-14 | $0.00 derived: sum of 2 quarters · filed 2013-08-14 | $0.00 10-Q · filed 2013-08-14 | $7.94K derived: sum of 4 quarters · filed 2013-08-14 | $224.67K 10-Q · filed 2012-08-17 | ||||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-17 | $0.00 10-Q · filed 2013-05-17 | $7.94K derived: sum of 3 quarters · filed 2013-05-17 | $10.29K derived: sum of 4 quarters · filed 2013-05-17 | $224.67K 10-Q · filed 2012-05-15 | ||||||||||||
| 2011-12-31 | $0.00 10-Q · filed 2013-02-14 | $7.94K derived: sum of 2 quarters · filed 2013-02-14 | $10.29K derived: sum of 3 quarters · filed 2013-02-14 | $21.29K derived: sum of 4 quarters · filed 2013-02-14 | $224.67K 10-Q · filed 2012-02-14 | ||||||||||||
| 2011-09-30 | $7.94K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-31 | $10.29K derived: sum of 2 quarters · filed 2012-12-31 | $21.29K derived: sum of 3 quarters · filed 2012-12-31 | $63.11K 10-K · filed 2012-12-31 | $224.67K 10-K · filed 2011-12-22 | ||||||||||||
| 2011-06-30 | $2.35K 10-Q · filed 2012-08-17 | $13.35K derived: sum of 2 quarters · filed 2012-08-17 | $55.17K 10-Q · filed 2012-08-17 | $216.73K 10-Q · filed 2011-08-12 | |||||||||||||
| 2011-03-31 | $11.00K 10-Q · filed 2012-05-15 | $52.82K 10-Q · filed 2012-05-15 | |||||||||||||||
| 2010-12-31 | $41.82K 10-Q · filed 2012-02-14 | ||||||||||||||||
| 2010-09-30 | $12.81K 10-K · filed 2011-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |